Literature DB >> 11239648

Favorable survival associated with microsatellite instability in endometrioid endometrial cancers.

G L Maxwell1, J I Risinger, A A Alvarez, J C Barrett, A Berchuck.   

Abstract

OBJECTIVE: To determine whether microsatellite instability in endometrioid endometrial cancer is associated with favorable survival.
METHODS: Microsatellite instability analysis was performed in 131 patients with endometrioid endometrial cancer using three polymorphic markers in paired cancer and normal DNA. Logistic regression and multivariable analyses calculated the relation between microsatellite instability, clinical features, and survival.
RESULTS: Microsatellite instability was detected in 29 of 131 (22%) endometrioid endometrial cancers. There was no correlation between microsatellite instability and age, race, grade, stage, or depth of myometrial invasion. Microsatellite instability was associated with better survival in univariate and multivariable analyses after controlling for confounding influences (P =.03). The 5-year survival rate of those with microsatellite instability was 77% (95% confidence interval 55%, 90%) compared with only 48% (95% confidence interval 39%, 57%) in other cases. Microsatellite instability was associated with other molecular features that predict favorable outcome including PTEN mutation (P =.002) and the absence of p53 overexpression (P =.01).
CONCLUSION: Microsatellite instability is a molecular alteration associated with favorable outcome in endometrioid endometrial cancers, even when accounting for other prognostic factors. This association might be explained by the finding that the pathway of molecular carcinogenesis characterized by loss of DNA mismatch repair favors alteration of genes that result in a less virulent clinical phenotype.

Entities:  

Mesh:

Year:  2001        PMID: 11239648     DOI: 10.1016/s0029-7844(00)01165-0

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  17 in total

Review 1.  Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic implications.

Authors:  Laura Cerezo; Higinia Cárdenes; Helen Michael
Journal:  Clin Transl Oncol       Date:  2006-04       Impact factor: 3.405

2.  Promoter hypermethylation of CIDEA, HAAO and RXFP3 associated with microsatellite instability in endometrial carcinomas.

Authors:  Yi-Wen Huang; Jingqin Luo; Yu-I Weng; David G Mutch; Paul J Goodfellow; David S Miller; Tim H-M Huang
Journal:  Gynecol Oncol       Date:  2010-03-07       Impact factor: 5.482

3.  hMLH1 promoter hypermethylation and MSI status in human endometrial carcinomas with and without metastases.

Authors:  J Bischoff; A Ignatov; A Semczuk; C Schwarzenau; T Ignatov; T Krebs; D Küster; D Przadka-Rabaniuk; A Roessner; S D Costa; R Schneider-Stock
Journal:  Clin Exp Metastasis       Date:  2012-05-03       Impact factor: 5.150

4.  High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases.

Authors:  Anita Steinbakk; Anais Malpica; Aida Slewa; Einar Gudlaugsson; Emiel A M Janssen; Mark Arends; Arnold Jan Kruse; Yu Yinhua; Weiwei Feng; Jan P Baak
Journal:  Cell Oncol (Dordr)       Date:  2011-05-06       Impact factor: 6.730

5.  DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice.

Authors:  Hong Wang; Wayne Douglas; Marie Lia; Winfried Edelmann; Raju Kucherlapati; Katrina Podsypanina; Ramon Parsons; Lora Hedrick Ellenson
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Microsatellite instability as a marker of prognosis: a systematic review and meta-analysis of endometrioid endometrial cancer survival data.

Authors:  Jing-Ping Xiao; Ji-Sheng Wang; Yuan-Yu Zhao; Jiang Du; Yun-Zi Wang
Journal:  Arch Gynecol Obstet       Date:  2022-06-04       Impact factor: 2.344

Review 7.  Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States.

Authors:  B Long; F W Liu; R E Bristow
Journal:  Gynecol Oncol       Date:  2013-05-23       Impact factor: 5.482

8.  Oviduct-specific glycoprotein is a molecular marker for invasion in endometrial tumorigenesis identified using a relevant mouse model.

Authors:  Hong Wang; Ayesha Joshi; Lori Iaconis; Garron J Solomon; Zhaoying Xiang; Harold G Verhage; Wayne Douglas; Brigitte M Ronnett; Lora Hedrick Ellenson
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

9.  Frequent mutations in the RPL22 gene and its clinical and functional implications.

Authors:  Akiva P Novetsky; Israel Zighelboim; Dominic M Thompson; Matthew A Powell; David G Mutch; Paul J Goodfellow
Journal:  Gynecol Oncol       Date:  2012-11-02       Impact factor: 5.482

Review 10.  Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.

Authors:  Sigurd F Lax
Journal:  Virchows Arch       Date:  2004-01-28       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.